CoChat

Steady‐state pharmacokinetics and glucodynamics of the novel, long‐acting basal insulin LY2605541 dosed once‐daily in patients with type 2 diabetes mellitus

Sinha, V. P., Howey, D. C., Choi, S. L., Mace, K. F., Heise, T. · 2014 · Diabetes, Obesity and Metabolism
Cited by 61

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Aims: To assess the pharmacokinetics ( PK ) and glucodynamics ( GD ) of LY2605541 in patients with type 2 diabetes mellitus. Methods: This parallel‐group, open‐label, dose‐escalation study examined the PK and GD of basal insulin LY2605541 after single and multiple‐dose administration. Fixed doses of LY2605541 (0.33–1.00 U/kg) were given once‐daily ( QD ) for 14 days to insulin‐treated patients with type 2 diabetes. A 24‐h euglycaemic glucose clamp was conducted on days 1 and 14. Results: PK steady state was achieved within 7–10 days and the peak‐to‐trough fluctuation was <2, translating to a nearly ‘peakless’ glucose infusion rate at steady state and with a duration of action of at least 24 h. Across dose levels t 1/2 ranged from 44.7 to 75.5 h (˜2–3 days). As steady state was achieved, there were dose‐dependent reductions in the prandial insulin dose and in fasting blood glucose, which decreased to 60–100 mg/dl across dose levels. Within‐patient variability was <14 and <26% for the area under the concentration versus time curve ( AUC ) of the 8‐point blood glucose profile and fasting blood glucose, respectively. The nocturnal glucose control between 03:00 and 09:00 hours was relatively unchanged. Mild hypoglycaemia was the most common adverse event. Conclusions: In this Phase I study of fixed LY2605541 doses without titration, LY2605541 was well‐tolerated and demonstrated a flat PK and GD profile accompanied by glucose normalization, prandial insulin dose reduction and no severe hypoglycaemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12222

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

Metadata

Authors
Sinha, V. P., Howey, D. C., Choi, S. L., Mace, K. F., & Heise, T.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2013-10-31
Volume
16
Issue
4
Pages
344-350
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W1721477966
Cited by
61
References
10
FWCI
11.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.